SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-22-002336
Filing Date
2022-03-01
Accepted
2022-03-01 16:10:29
Documents
15
Period of Report
2022-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A zivo_8ka.htm   iXBRL 8-K/A 28022
2 EMAIL FROM ANDREW DAHL DATED FEBRUARY 25, 2022 zivo_ex17.htm EX-17 5635
  Complete submission text file 0001654954-22-002336.txt   164581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zivo-20220218.xsd EX-101.SCH 5822
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20220218_lab.xml EX-101.LAB 15279
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20220218_cal.xml EX-101.CAL 890
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20220218_pre.xml EX-101.PRE 9720
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20220218_def.xml EX-101.DEF 2095
9 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8ka_htm.xml XML 4466
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40449 | Film No.: 22698063
SIC: 2836 Biological Products, (No Diagnostic Substances)